14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of DSGN
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Design Therapeutics, Inc. stock price ended at $3.82 on Monday, after gaining 2.96%.
(Updated on Jun 17, 2024)

Sell candidate since Jun 06, 2024 Loss -6.60% PDF

The Design Therapeutics, Inc. stock price gained 2.96% on the last trading day (Monday, 17th Jun 2024), rising from $3.71 to $3.82. During the last trading day the stock fluctuated 3.91% from a day low at $3.69 to a day high of $3.83. The price has fallen in 6 of the last 10 days and is down by -6.14% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 66 thousand more shares were traded than the day before. In total, 161 thousand shares were bought and sold for approximately $613.35 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.93% during the next 3 months and, with a 90% probability hold a price between $3.81 and $5.93 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

DSGN Signals & Forecast

Design Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Design Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.83 and $4.10. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 09, 2024, and so far it has fallen -19.92%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Design Therapeutics, Inc. stock

Design Therapeutics, Inc. finds support from accumulated volume at $3.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.144 between high and low, or 3.91%. For the last week, the stock has had daily average volatility of 5.64%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DSGN) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Design Therapeutics, Inc. to open at $3.78, and during the day (based on 14 day Average True Range), to move between $3.58 and $4.06, which gives a possible trading interval of +/-$0.238 (+/-6.23%) up or down from last closing price. If Design Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 12.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.80 (0.52%) than the resistance at $3.85 (0.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Design Therapeutics, Inc. stock A Buy?

The Design Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Design Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.308 Sell Candidate Unchanged

Predicted Opening Price for Design Therapeutics, Inc. of Tuesday, June 18, 2024

Fair opening price June 18, 2024 Current price
$3.78 ( 1.08%) $3.82

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for DSGN

Fibonacci Support & Resistance Levels

Level Price
R3 3.92 2.69%
R2 3.87 1.25%
R1 3.83 0.358%
Price 3.82
S1 3.72 -2.53%
S2 3.69 -3.42%
S3 3.63 -4.86%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.69 22.77%
R2 3.94 3.14%
R1 3.85 0.785%
Price 3.82
S1 3.80 -0.524%
S2 3.76 -1.57%
S3 3.74 -2.09%

FAQ

What is the symbol for Design Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Design Therapeutics, Inc. is DSGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Design Therapeutics, Inc. Stock?
The Design Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Design Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Design Therapeutics, Inc. Stock?
Design Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Design Therapeutics, Inc. Stock.

What's the current price of Design Therapeutics, Inc. Stock?
As of the end of day on the Jun 17, 2024, the price of an Design Therapeutics, Inc. (DSGN) share was $3.82.

What is the 52-week high and low for Design Therapeutics, Inc. Stock?
The 52-week high for Design Therapeutics, Inc. Stock is $8.31 and the 52-week low is $1.94.

What is the market capitalization of Design Therapeutics, Inc. Stock?
As of the Jun 17, 2024, the market capitalization of Design Therapeutics, Inc. is 215.811M.

When is the next earnings date for Design Therapeutics, Inc.?
The upcoming earnings date for Design Therapeutics, Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About Design Therapeutics, Inc.

Design Therapeutics. Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysf... DSGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT